Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...

CARMIEL, ISRAEL / ACCESS Newswire / September 11, 2025 / Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of ...

Mammalian expression systems lead the market, while prokaryotic systems grow fastest as biotech R&D investment surges worldwide.Austin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Protein Expression Market ...

Reagents are expected to dominate with 27.2% market share in 2025, thanks to their essential role in protein expression ...

The cost-effective, easy-to-use T7 expression system has been integral to Escherichia coli protein production since its introduction in 1986. Now, a just-developed enhancement is making it even better ...

Loopworm recently announced a Series A funding round to commercialize its proprietary recombinant protein platform, the ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that it has completed verification of its Entolimod™ cell line, the first step in establishing ...

India-based alternative feed startup Loopworm has opened a Series A funding round in support of its goal of scaling ...

CARMIEL, ISRAEL / ACCESS Newswire / September 11, 2025 / Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of ...